tetradecanoylphorbol acetate has been researched along with Coronary Artery Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geirsson, A; Khan, SF; Kim, RW; Lebastchi, AH; Li, W; Qin, L; Tellides, G; Zhou, J | 1 |
| Bassler, N; Diehl, P; El-Osta, A; Fricke, A; Helbing, T; Htun, N; Jowett, JB; Peter, K; Sander, L; Stamm, J; Ziemann, M | 1 |
| Amano, M; Higashi, M; Hiroki, J; Ichiki, T; Kaibuchi, K; Kandabashi, T; Kawamura, N; Kubota, T; Morikawa, K; Shimokawa, H; Takeshita, A | 1 |
| Cho, HS; Choo, YA; Hwang, M; Lee, TS; Park, KK | 1 |
| Berry, GJ; Diet, F; Dzau, VJ; Gibbons, GH; Momose, N; Pratt, RE | 1 |
5 other study(ies) available for tetradecanoylphorbol acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Activation of human vascular cells decreases their expression of transforming growth factor-beta.
Topics: Apoptosis; Calcium Ionophores; Case-Control Studies; Cells, Cultured; Coronary Artery Disease; Coronary Vessels; Down-Regulation; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-11; Ionomycin; Leukocytes; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Recombinant Proteins; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors; Transforming Growth Factor beta1 | 2011 |
Microparticles: major transport vehicles for distinct microRNAs in circulation.
Topics: Aged; Biological Transport; Biomarkers; Blood Platelets; Cell-Derived Microparticles; Cells, Cultured; Coronary Artery Disease; Endothelium, Vascular; Female; Gene Expression Profiling; Humans; Lipopolysaccharides; Male; MicroRNAs; Middle Aged; Monocytes; Severity of Illness Index; Tetradecanoylphorbol Acetate | 2012 |
Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells.
Topics: Angiotensin II; Coronary Artery Disease; Coronary Vessels; Gene Expression; Humans; Inflammation Mediators; Interleukin-1; Intracellular Signaling Peptides and Proteins; Muscle, Smooth, Vascular; Myocardium; NF-kappa B; Protein Kinase C; Protein Serine-Threonine Kinases; rho-Associated Kinases; RNA, Messenger; Tetradecanoylphorbol Acetate; Up-Regulation | 2004 |
Effects of bioactive ceramics on the pathogenesis of rat vascular smooth muscle cells treated with phorbol 12-myristate 13-acetate.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Ceramics; Coronary Artery Disease; Cyclooxygenase 2; Gene Expression Regulation; Inflammation Mediators; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Prostaglandins F; Rats; Tetradecanoylphorbol Acetate | 2008 |
Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.
Topics: Adolescent; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Aggregation; Cell Line; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Female; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Peptidyl-Dipeptidase A; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tissue Distribution | 1996 |